Quick Answer
LISATA THERAPEUTICS, INC. reported Stockholders Equity of $14.86 million for fiscal year 2025.
LISATA THERAPEUTICS, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $14.86M | -49.8% |
| 2024 | $29.57M | -38.6% |
| 2023 | $48.15M | -27.7% |
| 2022 | $66.58M | -27.8% |
| 2021 | $92.25M | +183.9% |
| 2020 | $32.50M | +56.1% |
| 2019 | $20.82M | -44.8% |
| 2018 | $37.73M | -25.3% |
| 2017 | $50.51M | +934.2% |
| 2016 | $4.88M | -79.4% |
| 2015 | $23.71M | -59.5% |
| 2014 | $58.51M | -6.4% |
| 2013 | $62.54M | +88.5% |
| 2012 | $33.18M | -46.5% |
| 2011 | $62.03M | +27.5% |
| 2010 | $48.66M | -15.9% |
| 2009 | $57.83M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $17.37M | -48.4% | -17.4% |
| June 30, 2025 | $21.03M | -45.0% | -17.1% |
| March 31, 2025 | $25.36M | -41.0% | -14.3% |
| December 31, 2024 | $29.57M | -38.6% | -12.2% |
| September 30, 2024 | $33.69M | -36.4% | -11.9% |
| June 30, 2024 | $38.25M | -34.0% | -11.0% |
| March 31, 2024 | $43.00M | -29.5% | -10.7% |
| December 31, 2023 | $48.15M | -27.7% | -9.1% |
- LISATA THERAPEUTICS, INC. showed a decrease of -49.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2009–2025 period, LISATA THERAPEUTICS, INC.’s stockholders equity has declined by 74.3% (from $57.83 million to $14.86 million).
- The most recent figure is from LISATA THERAPEUTICS, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: